If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

Share Price is delayed by 15 minutes
Get Live Data
112.75    -1.10 (-0.97%)
Bid:
112.70
Ask:
112.75
Spread: 0.05 (0.044%)
Market Cap: £65.57b
LLOY Live PriceLast checked at - London Stock Exchange

Intraday Lloyds Share Chart

Publication of Suppl.Prospcts

24 Oct 2025 11:33

RNS Number : 7785E
Lloyds Bank PLC
24 October 2025
Β 

RNS Announcement

Β 

Publication of Supplementary Prospectus

Β 

LLOYDS BANK PLC

(the Issuer)

Β 

€60 billion Global Covered Bond Programme, unconditionally and irrevocably guaranteed as to payments of interest and principal by Lloyds Bank Covered Bonds LLP

(the Programme)

Β 

Β 

24 October 2025

Β 

The following Supplementary Prospectus has been approved by the Financial Conduct Authority and is available for viewing:

Β 

Supplementary Prospectus dated 24 October 2025 (the Supplementary Prospectus) relating to the €60,000,000,000 Global Covered Bond Programme of Lloyds Bank plc, unconditionally and irrevocably guaranteed as to payments of interest and principal by Lloyds Bank Covered Bonds LLP.

Β 

The Supplementary Prospectus should be read and construed in conjunction with the prospectus dated 7 August 2025 (together, the Prospectus).

Β 

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

Β 

http://www.rns-pdf.londonstockexchange.com/rns/7785E_1-2025-10-24.pdf

Β 

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at National Storage Mechanism | FCA.

For further information, please contact:

Β 

Investor Relations

Douglas Radcliffe

Group Investor Relations Director

Email: douglas.radcliffe@lloydsbanking.com

Β 

Β 

+44 (0) 20 7356 1571

Β 

Group Corporate Affairs

Matt Smith

Head of Media Relations

Email: matt.smith@lloydsbanking.com

Β 

Β 

+44 (0) 7788 352 487

Group Corporate Treasury

Kristofer Middleton

Head of Term Issuance and Capital Structuring

Email: Kristofer.Middleton@lloydsbanking.com

Β 

+44 (0) 20 7356 1122

Β 

Lloyds Bank plcRegistered Office25 Gresham StreetLondon EC2V 7HN

Β 

Disclaimer - Intended Addressees

Β 

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

Β 

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States or to U.S. persons (as defined below) other than to qualified institutional buyers within the meaning of and in reliance on Rule 144A of the U.S. Securities Act of 1933, as amended (the Securities Act). The securities described herein have not been, and will not be, registered under the Securities Act or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. The securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America (as such terms are defined in Regulation S under the Securities Act) except pursuant to registration or an exemption from the registration requirements of the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and the Prospectus.

Β 

Your right to access this service is conditional upon complying with the above requirement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
PSPFLFVIIILSFIE
Date   Source Headline
7th Jul 20266:02 pmRNSTransaction in Own Shares
6th Jul 20266:08 pmRNSTransaction in Own Shares
3rd Jul 20266:03 pmRNSTransaction in Own Shares
2nd Jul 20266:00 pmRNSTransaction in Own Shares
1st Jul 20266:10 pmRNSTransaction in Own Shares
1st Jul 20262:00 pmRNSAdmission to Trading
30th Jun 20265:52 pmRNSTransaction in Own Shares
30th Jun 20264:00 pmRNSTotal Voting Rights
29th Jun 20266:05 pmRNSTransaction in Own Shares
26th Jun 20266:05 pmRNSTransaction in Own Shares
26th Jun 20262:00 pmRNSDirector/PDMR Shareholding
25th Jun 20266:21 pmRNSTransaction in Own Shares
25th Jun 202610:38 amRNSNotification of Redemption
24th Jun 20266:01 pmRNSTransaction in Own Shares
23rd Jun 20266:16 pmRNSTransaction in Own Shares
22nd Jun 20266:14 pmRNSTransaction in Own Shares
19th Jun 20266:07 pmRNSTransaction in Own Shares
19th Jun 20263:59 pmRNSDirector/PDMR Shareholding
18th Jun 20266:10 pmRNSTransaction in Own Shares
17th Jun 20266:15 pmRNSTransaction in Own Shares
17th Jun 20262:00 pmRNSDirector/PDMR Shareholding
16th Jun 20266:07 pmRNSTransaction in Own Shares
16th Jun 20267:00 amRNSTransaction in Own Shares
12th Jun 20266:15 pmRNSTransaction in Own Shares
12th Jun 20262:00 pmRNSDirector/PDMR Shareholding
11th Jun 20266:16 pmRNSTransaction in Own Shares
10th Jun 20266:01 pmRNSTransaction in Own Shares
10th Jun 20262:54 pmRNSPublication of a Supplementary Prospectus
10th Jun 202611:09 amRNSBoard Change
9th Jun 20265:51 pmRNSTransaction in Own Shares
8th Jun 20266:09 pmRNSTransaction in Own Shares
8th Jun 202612:28 pmRNSAdmission to Trading
5th Jun 20266:21 pmRNSTransaction in Own Shares
4th Jun 20266:04 pmRNSTransaction in Own Shares
4th Jun 20263:34 pmRNSPublication of Final Terms
3rd Jun 20266:08 pmRNSTransaction in Own Shares
2nd Jun 20265:59 pmRNSTransaction in Own Shares
2nd Jun 202611:52 amRNSConsent Solicitation Results Announcement
1st Jun 20266:17 pmRNSTransaction in Own Shares
29th May 20266:11 pmRNSTransaction in Own Shares
29th May 20263:35 pmRNSTotal Voting Rights
29th May 20262:00 pmRNSDirector/PDMR Shareholding
28th May 20266:21 pmRNSTransaction in Own Shares
27th May 20266:03 pmRNSTransaction in Own Shares
26th May 20266:16 pmRNSTransaction in Own Shares
26th May 20262:00 pmRNSDirector/PDMR Shareholding
26th May 20267:00 amRNSBlock Admission Application
22nd May 20266:04 pmRNSTransaction in Own Shares
22nd May 20262:00 pmRNSDirector/PDMR Shareholding
21st May 20266:08 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.